FACS: Use at an assay dependant concentration. FuncS: Use at an assay dependant dilution. MEM-43 inhibits the complement-protecting activity of CD59. IP: Use at an assay dependant concentration. WB: Use at an assay dependant concentration. Use under non-reducing conditions. Optimal dilutions/concentrations should be determined by the end user.
CD59 antigen (human). MEM-43 identified CD59 as the new cluster on 4th HLDA Workshop. MEM-43 reacts with well defined epitope (WhO, P-53).
Phosphate buffered saline pH 7.4 containing 15mM sodium azide
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
1mg/ml(Please refer to the vial label for the specific concentration.)
Thymocytes and T lymphocytes.
>95% by SDS-PAGE
Purified by protein A chromatography.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
MIN2, MIN3, PROTECTIN, MSK21, CD59, MIC11, 966, 107271, MIN1, P13987, MGC2354, 16.3A5, 1F5, EJ16, EJ30, EL32, FLJ38134, FLJ92039, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MIRL, p18-20, HRF 20, MAC IP, MACIP
CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
GTX29182 FACS Image
Surface staining of human peripheral blood cells with anti-human CD59: PE (GTX74619).